Welcome to the PharmCast Research Store. Gain access to market leading research in your industry. You can browse through the portfolio of reports below or enter keywords in the search box to find the information you have been looking for.
  • Browse Reports & Briefs
  • Browse Company Profiles
  • Browse Industry Profiles
  • Latest News
Number of Employees

< 250 (30)

250 - 999 (22)

1,000 - 2,499 (20)

2,500 - 4,999 (29)

5,000 - 9,999 (56)

10,000 - 49,999 (113)

50,000+ (40)

Annual Revenue US$m

< 50 (19)

50 - 99 (7)

100 - 199 (8)

200 - 499 (20)

500 - 999 (11)

1,000 - 1,999 (45)

2,000+ (189)

Top stories

Johnson & Johnson announces start of Phase I Ebola vaccine trial

Johnson & Johnson has announced the start of a Phase I, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies...more >>

Torii files NDA for house dust mite allergy immunotherapy tablet with MHLW

Torii Pharmaceutical Co., Ltd. has filed a new drug application, or NDA, for TO-203, an allergen immunotherapy tablet for house dust mite allergy, for the indication of allergic rhinitis with the Japanese Ministry of Health, Labour and Welfare, or MHLW...more >>

Boehringer Ingelheim enrolls first patient in COPD study

Boehringer Ingelheim has enrolled the first patient in its large-scale DYNAGITO study to investigate effect of tiotropium + olodaterol Respimat on exacerbations in chronic obstructive pulmonary disease, or COPD...more >>

Johnson & Johnson forms consortia for Ebola vaccine development

Johnson & Johnson has formed consortia with London School of Hygiene & Tropical Medicine, University of Oxford, Institut National de la Sante et de la Recherche Medicale, or INSERM, La Centre Muraz, Bavarian Nordic A/S, Vibalogics, Grameen Foundation and World Vision of Ireland to work in conjunction with Janssen Pharmaceutical Companies for the development of its Ebola vaccine regimen...more >>